RNA Avidity Sotuvning sof marjinal rentabelligi

Avidity (RNA) korporativ emblemasi va logotipi

Avidity Biosciences (RNA) mushak distrofiya bilan kurashish uchun AOC konjugatlarini ishlab chiqishda katta yutuqlarga erishmoqda. Sotuvlardan olingan sof foyda ushbu o'sishni aks ettiradi, bunda -180.90 darajasi joriy qiymatni ifodalaydi. Barqarorlik noyob patologiyalar portfelining diversifikatsiyasi orqali ta'minlanadi, barqaror rivojlanish esa qat'iy bioetik standartlar va laboratoriyalarning ekologik nazoratiga asoslangan.

Avidity Biosciences (RNA) - Sof marja 04.07.2022dan 19.11.2026gacha

Avidity (RNA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning har tomonlama tahlili:Avidity Biosciences
Avidity Biosciences Inc yetakchi tovari

Avidity Biosciences (RNA) kompaniyasining sof daromadliligi tushumdan barcha operatsion xarajatlar va soliqlarni chegirib tashlagandan keyin qolgan foyda qismini aks ettiradi, bu esa shifokorlar va olimlar uchun yuqori mehnat xarajatlarini hisobga olgan holda juda muhimdir. Kompaniyaning sof marjasini tahlil qilish orqali investor RNA terapiyasi sintezini avtomatlashtirish biznesning uzoq muddatli moliyaviy barqarorligini ta'minlash uchun klinik sinovlar xarajatlarini qanchalik samarali qoplayotganini baholashi mumkin.

Avidity Biosciences (RNA) raqobatchilari

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi CRSP|Kompaniya sotuv marjasi GeneDx|Sof marja Ultragenyx RARE|Kompaniya sotuv marjasi Beam Therapeutics (BEAM)|SRPT: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Twist Bioscience|TXG (10x Genomics) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX